Clinical Trials Browser

Phase 1/2 × Neoplasm, Residual × Daunorubicin × Clear all

NCT03760445 2020-01-09

HDM201 Added to CT in R/R or Newly Diagnosed AML

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual